Bhama Ramkhelawon;Aranzazu Mediero-Munoz;Bruce N Cronstein;Kathryn J Moore
发明人:
Bruce N Cronstein,Kathryn J Moore,Aranzazu Mediero-Munoz,Bhama Ramkhelawon
申请号：
US14058392
公开号：
US09381245B2
申请日:
2013.10.21
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention provides methods and compositions for reducing or inhibiting osteolysis, bone resorption, osteoclast differentiation and stimulation and the loosening of medical prostheses by administering a compound or agent that inhibits the biological activity of an axon guidance protein. The compound or agent my inhibit transcription or translation of or bind to an axon guidance protein, such as, for instance, a netrin like netrin-1. Likewise, the compound or agent may inhibit transcription or translation of or bind to a receptor of an axon guidance protein, such as, for instance, a netrin receptor such as unc5b. In some instances, the compound or agent is an agonist of an adenosine A2A receptor. The invention also extends to pharmaceutical compositions comprising such compounds and agents.
